ArticleCureus2026
Solitary Fibrous Tumor With a 12-Year Recurrence Interval in a Female Patient: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm characterized by unpredictable biological behavior, with the potential for late recurrence even in tumors initially classified as low risk. We report the case of an 83-year-old woman with a history of complete resection of a right thoracic SFT 12 years earlier, who was found on surveillance imaging to have a new anterior left mediastinal mass. Positron emission tomography-computed tomography (PET-CT) demonstrated low metabolic activity (maximum standardized uptake value (SUVmax) 2.32). Surgical exploration revealed a 6.5 × 5 cm lesion adherent to the pericardial pleura, which was completely resected. Histopathologic examination showed a spindle cell neoplasm with a patternless architecture, without hypercellularity, necrosis, or pleomorphism. Immunohistochemistry demonstrated strong nuclear positivity for signal transducer and activator of transcription 6 (STAT6) and diffuse CD34 expression, with negative S100 protein and muscle markers. Risk stratification using the Demicco model categorized the tumor as low risk. Review of the original tumor resected in 2013, which measured 19.3 × 16.2 cm, revealed similar histologic features and an intermediate-risk score. The long disease-free interval raises the diagnostic dilemma of late recurrence versus a metachronous SFT, a distinction that remains challenging due to shared morphologic and molecular characteristics. This case underscores the limitations of metabolic imaging in indolent SFTs and highlights the importance of complete surgical resection and long-term, potentially lifelong, surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.